Axa’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-13,100
Closed -$1.11M 1391
2020
Q3
$1.11M Sell
13,100
-46,300
-78% -$2.34M ﹤0.01% 924
2020
Q2
$2.1M Buy
+59,400
New +$1.74M 0.01% 821
2017
Q4
Sell
-33,000
Closed -$461K 1411
2017
Q3
$461K Buy
+33,000
New +$329K ﹤0.01% 1118

Axa's IMMU Position: Q4 2020 in Review

Axa sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 13,100 shares — an estimated $1.11M sold.

Axa first reported a position in IMMU in Q3 2017 and held it in 3 quarters. The position peaked at $2.1M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Axa reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Axa sold 13,100 Immunomedics Inc shares in Q4 2020, an estimated $1.11M.
  • Axa first reported a position in Immunomedics Inc in Q3 2017 and held it in 3 quarters.
  • Axa's Immunomedics Inc position peaked at $2.1M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.